Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Comment by BurconNutriFanon May 08, 2018 12:49pm

86 Views

Post# 27998514

RE:Phase II - primary outcome measure

Valuation - lets not forget Hemophilia which also is an annual 10 billion market. Sernova is using autograft which means they are use the patients own endothelial cells to correct gene defect to produce a constant factor 8! That alone might be worth several dollars a share. This will be taken out by a major way before that.

Bullboard Posts

Two micro-cap stocks with strong fundamentals